Greil, C., Engelhardt, M., Ihorst, G., Schoeller, K., Bertz, H., Marks, R., Zeiser, R., Duyster, J., Einsele, H., Finke, J., & Wäsch, R. [ca. 2019]. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life [Cd]. Freiburg: Universität. https://doi.org/10.3324/haematol.2018.200881

GREIL, Christine, ENGELHARDT, Monika, IHORST, Gabriele, SCHOELLER, Katja, BERTZ, Hartmut, MARKS, Reinhard, ZEISER, Robert, DUYSTER, Justus, EINSELE, Hermann, FINKE, Jürgen und WÄSCH, Ralph, 2019. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Freiburg: Universität.

Greil, C., M. Engelhardt, G. Ihorst, K. Schoeller, H. Bertz, R. Marks, R. Zeiser, J. Duyster, H. Einsele, J. Finke, und R. Wäsch. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. cd, Universität, 2019, https://doi.org/10.3324/haematol.2018.200881.

Greil, Christine/Engelhardt, Monika/Ihorst, Gabriele/Schoeller, Katja/Bertz, Hartmut/Marks, Reinhard u. a.: Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life, Freiburg 2019.

Greil, C., Engelhardt, M., Ihorst, G., Schoeller, K., Bertz, H., Marks, R., Zeiser, R., Duyster, J., Einsele, H., Finke, J. und Wäsch, R. (2019), Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life, Bd. , Universität, Freiburg, verfügbar unter:https://doi.org/10.3324/haematol.2018.200881.